SCHEMBL10708779

SCHEMBL10708779

NCCC(C(=O)O)C(=O)c1ccncc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.45
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MPO P05164 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2A6 P11509 1/20 0.44
ALDH1A1 P00352 2/20 0.42
PLOD2 O00469 1/20 0.42
PLOD3 O60568 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
PLOD1 Q02809 1/20 0.42
HIF1A Q16665 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GRM8 O00222 1/20 0.40
GRM4 Q14833 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6900351 0.80 ALDH1A1 (0.51) CYP2C19ALDH1A1PLOD2CYP2C9KMT2A
SCHEMBL4424991 0.78 NAPRT (0.48) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL27885703 0.75 ALDH1A1 (0.55) CYP1A2CYP2D6ALDH1A1MEN1KMT2A
SCHEMBL5439920 0.74 GSR (0.48) MDM2
SCHEMBL28624819 0.73 NAPRT (0.52) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL10592278 0.72 GRM8 (0.48) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL9755838 0.72 GRM8 (0.48) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL6007952 0.72 NAPRT (0.50) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL6007960 0.72 NAPRT (0.50) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL9164237 0.71 CYP1A2 (0.42) NAPRTCYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012167243-A1 COMPOSITIONS AND METHODS OF TREATMENT FOR OBESITY B & P COMPANY, INC. (US) 2012-12-06 WO claimed
WO-2012167243-A1 COMPOSITIONS AND METHODS OF TREATMENT FOR OBESITY B & P COMPANY, INC. (US) 2012-12-06 WO disclosed
EP-0170933-B1 GAMMA-AMINOBUTYRIC ACID DERIVATIVES, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS KURARAY CO., LTD. (JP) 1988-08-31 EP disclosed
US-4703061-A MEMORY IMPEDIMENT; BRAIN METABOLISM DYSFUNCTION KURARAY CO., LTD. (JP) 1987-10-27 US disclosed
EP-0170933-A1 Gamma-aminobutyric acid derivatives, process for production thereof, and use thereof as medicaments KURARAY CO., LTD. (JP) 1986-02-12 EP disclosed